You have 9 free searches left this month | for more free features.

2-Aminopurine

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (NBTXR3, Cetuximab, Radiation Therapy)

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tampa, Florida
  • +17 more
Mar 22, 2022

Status Asthmaticus Trial in Karachi (Magnesium Sulfate 500 mg/ml+ ventolin, Ventolin)

Enrolling by invitation
  • Status Asthmaticus
  • Magnesium Sulfate 500 mg/ml+ ventolin
  • Ventolin
  • Karachi, Sindh, Pakistan
    Rabia Asif
Feb 24, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib Lenalidomide Dexamethasone
  • Isatuximab Carfilzomib Lenalidomide Dexamethasone
  • Ostrava, Czechia
  • +6 more
Jul 26, 2022

SARS-CoV-2 Trial in Melbourne (Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59),

Recruiting
  • SARS-CoV-2
  • Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59)
  • +2 more
  • Melbourne, Victoria, Australia
  • +1 more
Apr 25, 2022

Exercise Program, Type2diabetes Trial in Burdur (Online-supervised exercise group, Unsupervised-exercise training group)

Completed
  • Exercise Program
  • Type2diabetes
  • Online-supervised exercise group
  • Unsupervised-exercise training group
  • Burdur, Turkey
    Burdur Mehmet Akif Ersoy University
Oct 11, 2022

Alzheimer, Mild Cognitive Impairment Trial in Charlestown (tACS device)

Not yet recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • tACS device
  • Charlestown, Massachusetts
    Massachusetts General Hospital
Jun 6, 2023

COVID-19, Hematopoietic Stem Cell Transplantation Trial in Tianjin (COVID Convalescent Plasma)

Recruiting
  • COVID-19
  • Hematopoietic Stem Cell Transplantation
  • COVID Convalescent Plasma
  • Tianjin, None Selected, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 13, 2023

Diabetes Type 2 Trial (Behavioral and drugs already approved and available for diabetes management)

Recruiting
  • Diabetes Type 2
  • Behavioral and drugs already approved and available for diabetes management
  • Portage La Prairie, Manitoba, Canada
    Portage Clinic
Nov 14, 2022

B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

Recruiting
  • B-cell Lymphoma
  • LP-168 tablet
  • Beijing, Beijing, China
  • +2 more
Feb 24, 2022

Cancer in the Adventist Health Study-2

Active, not recruiting
  • Cancer, Breast
  • +2 more
    • Loma Linda, California
      Loma Linda University
    Nov 9, 2021

    Attention Deficit Disorder With Hyperactivity Trial in United States (CTN SR, Matching )

    Completed
    • Attention Deficit Disorder With Hyperactivity
    • CTN SR
    • Matching placebo
    • Newport Beach, California
    • +3 more
    Oct 14, 2021

    Post-COVID-19 Syndrome, Long-COVID-19 Syndrome Trial in Ennepetal (Aerobic Exercise Training)

    Completed
    • Post-COVID-19 Syndrome
    • Long-COVID-19 Syndrome
    • Aerobic Exercise Training
    • Ennepetal, NRW, Germany
      Clinic Königsfeld
    Aug 29, 2023

    Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior

    Not yet recruiting
    • Soft Tissue Sarcoma
    • Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
    • Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
    • Bordeaux, France
    • +10 more
    Aug 28, 2023

    Darvadstrocel for Crohn's Fistula in the Realworld

    Completed
    • Crohn's Fistula
    • Madrid, Spain
      Fundacion Jimenez Diaz
    Feb 21, 2023

    AML, MDS Trial in Tianjin (XZB-0004)

    Not yet recruiting
    • AML
    • MDS
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma Trial (TT-4)

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • (no location specified)
    Apr 26, 2022

    Healthy Volunteers Trial in Antwerp (BMO-2, EU-Humira, US-Humira)

    Completed
    • Healthy Volunteers
    • BMO-2
    • +2 more
    • Antwerp, Belgium
      SGS Belgium NV
    Mar 9, 2022

    Meniscus Lesion, Cartilage Injury, ACL Injury Trial in Zurich (Ultrahigh Field MRI at 7T)

    Recruiting
    • Meniscus Lesion
    • +2 more
    • Ultrahigh Field MRI at 7T
    • Zurich, Switzerland
      Balgrist University Hospital
    Aug 11, 2022

    Amputation, Phantom Limb Pain, Hoffman's Reflex Trial in Pittsburgh (Transcutaneous spinal cord stimulation)

    Completed
    • Amputation
    • +2 more
    • Transcutaneous spinal cord stimulation
    • Pittsburgh, Pennsylvania
    • +1 more
    Aug 11, 2022

    Vitamin D Intervention in Infants - 6 Years Follow-up (VIDI2)

    Completed
    • Bone Strength
    • +5 more
      • Helsinki, Finland
        Children's Hospital
      Oct 31, 2022

      Head Neck Cancer Trial in Tübingen (Real-time ADC-guided response adaptive Boost in HNC)

      Recruiting
      • Head and Neck Cancer
      • Real-time ADC-guided response adaptive Boost in HNC
      • Tübingen, BW, Germany
        UKT Radiooncology
      Jan 31, 2022

      COVID-19 Trial in Monterrey (Placebo, Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS))

      Recruiting
      • COVID-19
      • Placebo
      • Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS)
      • Monterrey, Nuevo Leon, Mexico
        Hospital San José
      Oct 20, 2021

      Metastatic Solid Tumor Trial ([18F]AlF-RESCA-IL2 PET scan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • [18F]AlF-RESCA-IL2 PET scan
      • (no location specified)
      Jul 20, 2022

      High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

      Recruiting
      • High Risk Acute Myeloid Leukemia
      • Allogeneic Hematopoeitic Stem Cell Transplantation
      • Shanghai, Shanghai, China
        Shanghai general hospital, Shanghai Jiaotong university school o
      Oct 10, 2021

      High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

      Recruiting
      • High Risk Acute Myeloid Leukemia
      • Allogeneic Hematopoeitic Stem Cell Transplantation
      • Shanghai, Shanghai, China
        Shanghai general hospital, Shanghai Jiaotong university school o
      Oct 10, 2021